ØRSTA: Arctic Bioscience AS has engaged ABG Sundal Collier ASA and DNB Markets as joint global coordinators and joint bookrunners for a contemplated private placement raising gross proceeds of NOK 250 million and admission to trading of the Company’s shares on Euronext Growth Oslo. Arctic Bioscience is a biotech company founded based on specialised know-how…